Novartis Plays Long Game With Antares Deal - Meaning Near-Term Upside Unlikely (NYSE:NVS)

Antares-Novartis AG oncology partnership: $105M upfront, up to $1.8B milestones, and what it signals for NVS amid patent cliffs. Click for this look at the deal.

Read on WOBR AI →